This is to inform you that 36th Annual General Meeting of the Company for the Financial Year 2024-25 is scheduled to be held on Saturday, September 20, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has announced its 36th Annual General Meeting (AGM) for the financial year 2024-25, scheduled for Saturday, September 20, 2025 at 12:00 Noon at its registered office in Virar (E), Palghar. The ordinary business includes adoption of audited financial statements for the year ended March 31, 2025, and the re-appointment of Mrs. Srijna Sharma (DIN: 00078169), who retires by rotation. Two special business items seek shareholder approval for appointing Mr. Munna Baijnath Chaurasia and Mr. Aman Mukesh Chaudhari as Independent Directors for a five-year term starting March 27, 2025. Remote e-voting will be open from September 17 to September 19, 2025, with a cut-off/record date of September 13, 2025. The Register of Members will be closed from September 14 to September 20, 2025.
This is a routine AGM notice with no material financial action items; the key items are standard governance matters (adoption of accounts, director re-appointment, and two new independent director appointments). No immediate impact on share price is expected.